Biomedical subjects

Byung-Kook Kim

Publications and source records attributed to Byung-Kook Kim.

3 recordsLinked to original sources

PubMed2006

Detection method for ionic species based on the electroacoustic effect.

The development and application of a new ion detection method based on the electroacoustic (EA) effect is described. An EA signal, produced by applying a pulsed-type electric field to an electrolyte solution in an electroacoustic cell, is dependent on the electrical and thermal properties of the electrolyte and can be detected by using a conventional gas microphone system. The EA signals, generated in this fashion, are proportional to the square of the amplitude of the pulsed-type electric field and show an inverse dependence on the modulated frequency, as found in other acoustic detection systems. The results of this study demonstrate that the EA signals observed with the new system display a linear dependence on the concentration of the electrolyte over a 3 order-of-magnitude concentration range (ca. 10(-7)-10(-4) M). The detection limit of this system was shown to be as low as 29.9 ppb for an aqueous solution of HCl. The results also indicate that the EA signal is proportional to the equivalent conductivity of electrolytes in aqueous solution. As a consequence, the new method has the potential of being used as a universal detector for ions in solutions. An important property of this detection system is that it can be applied to in situ ion detection, and as a result, it can be employed in kinetic studies to follow the progress of ionic chemical reactions.

Journal Article↗

PubMed2004

Agranulocytosis induced by vancomycin in an ESRD patient on CAPD.

Agranulocytosis is a rare adverse effect associated with prolonged vancomycin therapy, and is potentially serious, especially in end stage renal disease (ESRD) patients. We describe a continuous ambulatory peritoneal dialysis (CAPD) patient that developed vancomycin-induced agranulocytosis during treatment for methicillin-resistant Staphylococcus aureus (MRSA)-associated external cuff infection and pneumonia. The agranulocytosis was rapidly resolved by granulocyte colony-stimulating factor (G-CSF) therapy and by the discontinuation of vancomycin.

Aged↗

PubMed2003

Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.

To compare survival rates and long-term complications after bone marrow transplantation (BMT) or treatment with immunosuppressive agents (ISA) in the management of adult aplastic anemia (AA) and to identify prognostic factors associated with improved survival, we evaluated 229 adult AA patients treated with ISA from 1990 to 2001 and compared the results with those for 64 BMT recipients. Of 156 patients with severe aplastic anemia (SAA) or very severe AA treated with ISA (antithymocyte globulin [ATG] or ATG plus cyclosporine), 46.8% showed complete or partial response and 7.1% had relapses. After long-term follow-up, 1 case each of acute leukemia, myelodysplastic syndrome, and paroxysmal nocturnal hemoglobinuria developed. The 6-year survival rate was 69%. Response to ISA, disease severity, and low absolute neutrophil count (ANC) (< or = 200/mm3) were associated with poor survival. Patient age, sex, initial platelet count, etiology, or treatment regimen did not significantly affect survival. Cox regression analysis showed low ANC to be the only pretreatment variable significantly associated with poor survival (P = .000). Of 64 BMT recipients, 82.8% had sustained engraftment, and 12.5% experienced graft failure. Twenty (31.3%) of the patients developed grade II to IV acute graft-versus-host disease (GVHD), and 12 (18.8%) of the patients developed chronic GVHD. The 6-year survival rate was 79%. Patient age and sex, disease severity, etiology, ANC, initial platelet count, and treatment regimen did not affect survival. Survival of 83 AA patients, aged 14 to 40 years, treated with ISA was not statistically significant from that of 61 adult AA patients who underwent BMT (6-year survival rate, 65% and 79%, respectively). However, BMT in adult AA achieved long-term engraftment and a lower relapse rate than ISA. These results suggest that ISA can achieve a high response rate and long-term survival among patients with adult AA, regardless of disease severity. Further studies with larger numbers of patients and long-term follow-up are needed.

Adolescent↗